Symyoo
11
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
9.1%
1 terminated/withdrawn out of 11 trials
88.9%
+2.4% vs industry average
36%
4 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
A Study of PLH-2301 in Subjects With Sarcopenia
Role: collaborator
Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients
Role: collaborator
A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation
Role: collaborator
Safety and Efficacy of CDFR0612 and CDFR0613 for Bowel Cleansing Before Colonoscopy
Role: collaborator
Drug-Drug Interaction of Clomipramine HCl and Sildenafil Citrate in Healthy Males
Role: collaborator
GCPGC in Chemotherapy-induced Neutropenia
Role: collaborator
Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients
Role: collaborator
GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock
Role: collaborator
Trial of PED-1 in Male Patients With Premature Ejaculation
Role: lead
Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation
Role: lead
To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin
Role: collaborator
All 11 trials loaded